Zografos L - Search Results

1

Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma.

Mantel I, Schalenbourg A, Bergin C, Petrovic A, Weber DC, Zografos L. Mantel I, et al. Among authors: zografos l. Am J Ophthalmol. 2014 Oct;158(4):693-701.e2. doi: 10.1016/j.ajo.2014.07.002. Epub 2014 Jul 14. Am J Ophthalmol. 2014. PMID: 25034116

2

Metastatic melanoma in the eye and orbit.

Zografos L, Ducrey N, Beati D, Schalenbourg A, Spahn B, Balmer A, Othenin-Girard CB, Chamot L, Egger E. Zografos L, et al. Ophthalmology. 2003 Nov;110(11):2245-56. doi: 10.1016/j.ophtha.2003.05.004. Ophthalmology. 2003. PMID: 14597536

3

Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study.

Mantel I, Uffer S, Zografos L. Mantel I, et al. Among authors: zografos l. Am J Ophthalmol. 2009 Dec;148(6):932-8.e1. doi: 10.1016/j.ajo.2009.06.032. Epub 2009 Oct 2. Am J Ophthalmol. 2009. PMID: 19800613

4

Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.

Konstantinidis L, Mantel I, Zografos L, Ambresin A. Konstantinidis L, et al. Among authors: zografos l. Eur J Ophthalmol. 2010 Sep-Oct;20(5):955-8. doi: 10.1177/112067211002000524. Eur J Ophthalmol. 2010. PMID: 20306440

5

Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications.

Mantel I, Schalenbourg A, Zografos L. Mantel I, et al. Among authors: zografos l. Am J Ophthalmol. 2012 May;153(5):910-922.e2. doi: 10.1016/j.ajo.2011.10.017. Epub 2012 Feb 4. Am J Ophthalmol. 2012. PMID: 22310077

6

Baerveldt shunts in the treatment of glaucoma secondary to anterior uveal melanoma and proton beam radiotherapy.

Sharkawi E, Oleszczuk JD, Bergin C, Zografos L. Sharkawi E, et al. Among authors: zografos l. Br J Ophthalmol. 2012 Aug;96(8):1104-7. doi: 10.1136/bjophthalmol-2011-301420. Epub 2012 May 24. Br J Ophthalmol. 2012. PMID: 22628537

7

Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.

Tran BK, Schalenbourg A, Bovey E, Zografos L, Wolfensberger TJ. Tran BK, et al. Among authors: zografos l. Retina. 2013 Oct;33(9):1777-83. doi: 10.1097/IAE.0b013e318295f758. Retina. 2013. PMID: 23792487

8

Evanescent vaso-occlusive choroidal pseudo-tumor with acute painful onset: a presumed vortex vein occlusion.

Mantel I, Schalenbourg A, Zografos L. Mantel I, et al. Among authors: zografos l. Graefes Arch Clin Exp Ophthalmol. 2014 May;252(5):753-9. doi: 10.1007/s00417-013-2543-9. Epub 2013 Dec 21. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 24362811

9

Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.

Petrovic A, Bergin C, Schalenbourg A, Goitein G, Zografos L. Petrovic A, et al. Among authors: zografos l. Ophthalmology. 2014 Apr;121(4):898-904. doi: 10.1016/j.ophtha.2013.10.032. Epub 2014 Jan 7. Ophthalmology. 2014. PMID: 24405742 Free article.

10

Good long-term visual outcomes of parapapillary choroidal melanoma patients treated with proton therapy: a comparative study.

Pica A, Weber DC, Vallat L, Bergin C, Hrbacek J, Schweizer C, Zografos L, Schalenbourg A. Pica A, et al. Among authors: zografos l. Int Ophthalmol. 2021 Feb;41(2):441-452. doi: 10.1007/s10792-020-01594-z. Epub 2020 Sep 25. Int Ophthalmol. 2021. PMID: 32975693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters